Noble-75
“Device manufacturers and stakeholders, including biopharma companies, healthcare providers, payers and patients, have realised the benefits and importance of training prior to initial self-injections, continuous training and onboarding throughout disease management to counteract administration training decay, and ultimately the role of training and onboarding to help improve adherence and health outcomes.”